Quidel Corporation Announces Joint Development and Commercialization Agreement with BioHelix Corporation

News   Oct 08, 2009

 
Quidel Corporation Announces Joint Development and Commercialization Agreement with BioHelix Corporation
 
 
 

RELATED ARTICLES

Genetics of Mitochondrial Mutation Exposed

News

A study has revealed how fatal mitochondrial disease can appear unexpectedly in families without history of such diseases.

READ MORE

Ancient Fish Genes May Hold Key to Spinal Cord Repair

News

A study has found that genes controlling spinal cord repair in the lamprey fish are also active in mammals, which could provide a blueprint for treatment.

READ MORE

Prostate Tumor Progression Dictated by Cancer’s Gene-determined “Immune Landscape”

News

The field of immunotherapy is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of patients, suggesting that as-yet unidentified variations among tumors result in distinct paths of disease progression and response to therapy.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE